Hiroki Hamamoto

Osaka Medical and Pharmaceutical University

Also affiliated with Takatsuki General Hospital, Osaka University of Pharmaceutical Sciences

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2– Breast Cancer: A New Role for ESR1?”.

ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2– Breast Cancer: A New Role for ESR1?

Annals of Surgical Oncology(2025)10.1245/s10434-025-18377-4

N/A

0DataRank · unranked

0 citations

Kohei Chida, Rongrong Wu, Kohei Taniguchi, Amber McKenery, Brian Morreale +17 more